Biosimulation Companies

Simulations Plus acquires Immunetrics: This strengthens Simulations Plus' quantitative systems pharmacology (QSP) expertise and expands its reach in oncology, immunology, and autoimmune diseases.

Certara partners with Infosys: This collaboration aims to integrate Certara's biosimulation software with Infosys' life sciences cloud platform, offering more accessible and scalable modeling solutions.

Thermo Fisher Scientific and Simulia collaborate: This partnership focuses on developing digital twins for bioreactors, allowing for real-time monitoring and optimization of biomanufacturing processes.

Certara unveils SimCyp Pediatric 5.0: This latest version of their popular pharmacokinetic (PK) simulation platform features an expanded pediatric database and new modeling capabilities for pediatric drug development.

Physiomics launches the Virtual Tumor Suite 5.0: This upgraded software offers improved tumor growth and treatment response prediction for personalized medicine applications.

Advanced Chemistry Labs introduces the NMRView® Exchange software: This innovative tool automates the analysis of biomolecular interactions using nuclear magnetic resonance (NMR) spectroscopy.

• Dassault Systèmes (France)


• Certara USA, Inc. (US)


• Simulation Plus (US)


• Schrödinger (US)


• Chemical Computing Group (Canada)


• Physiomics (UK)


• In Silico Biosciences (US)


• Advanced Chemistry Development, Inc. (Canada)


• Genedata AG (Switzerland)


• Nuventra Pharma (US)


• Evidera (US)


• Leadinvent Technologies (India)


• LeadScope, Inc. (US)


• Rosa (US)


• INOSIM Software GmbH (Germany)